Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review

Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review

BackgroundInterleukin (IL)-1 inhibitors represent the main treatment in patients with colchicine-resistant/intolerant familial Mediterranean fever (crFMF), mevalonate kinase deficiency (MKD), and tumor necrosis factor receptor-associated periodic syndrome (TRAPS). However, the reasons for the use of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Caroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, Catherine Barbier, Alexandre Belot, Manel Mejbri, Pascal Pillet, Jana Pachlopnik, Sylvaine Poignant, Charlotte Rebelle, Andreas Woerner, Isabelle Koné-Paut, Véronique Hentgen
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
autoinflammatory diseases
indications
treatment
hereditary recurrent fevers
interleukin-1 blockers
anakinra
Immunologic diseases. Allergy
RC581-607
Accès en ligne:https://doaj.org/article/26ad2c1c806644ef91dc77d124b1103b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/26ad2c1c806644ef91dc77d124b1103b

Documents similaires